Trump is rebuilding a tariff wall that was struck down in February 2026, when the Supreme Court ruled levies issued under the International Emergency Economic Powers Act were illegal.

Today’s world is more unpredictable than ever. From regulatory upheavals and trade tariffs to sudden shifts in consumer demand, businesses must be ready to respond swiftly and decisively. Traditional planning processes struggle to keep up with the urgent risks and opportunities that arise between meetings, triggering constant re-planning and creating room for misalignment and disorder.

Companies will need to take more ownership of workforce development through tailored training, upskilling and clearer pathways into technical roles, says the CEO of Orion Talent.

Maintaining exceptional service levels to ensure quality patient care is critical to AstraZeneca, a biopharmaceutical company.  But for years, its exceptional service levels came at a cost for the company in the form of elevated inventory levels and planning decisions made with limited end-to-end visibility into its supply chain, which impacted agility and growth.

Life sciences supply chains are among the most complex in the world. Every day, supply chain leaders must balance shifting demand, constrained supply, and strict regulatory requirements, all while ensuring patients get the medications they need. The margin for error is small, and disconnected, stage-by-stage planning just cannot keep up.

How do you plan for a technology that doesn't exist yet, while keeping today's production lines running? That's the challenge Bekaert faced with its titanium fiber-based porous transport layers, a breakthrough component powering industrial-scale green hydrogen production

Family-owned Giant Eagle generates about $9 ⁠billion in annual sales and operates around 200 supermarkets ⁠and 11 standalone pharmacies in Ohio, Pennsylvania, West Virginia, Maryland and Indiana.

Can artificial intelligence be trusted to manage logistics for an industry in which mistakes could be a matter of life or death?

UPS said that the $48 million investment will be used to improve delivery speeds, helping them stay ahead of rising demand for temperature-sensitive medications.

AstraZeneca selected supply chain planning software provider OMP to help redefine the biopharmaceutical giant's global planning capabilities.